drug:eloralinitide Amylin, with and without GLP1: Eloralinitide We dig into early results around Eloralinitide, an amylin-based weight loss formulation being developed by Eli Lilly.
company:eli-lilly Eli Lilly's big Summer 2025 update We take a look at some exciting upcoming presentations by Eli Lilly about it's old and new GLP1 receptor agonists.
